AI-generated summary
The authors randomly assigned 45 patients with refractory meibomian gland dysfunction, 90 eyes in total, to intense pulsed light combined with gland expression or to gland expression alone. The combined treatment group reported improvements in tear film measures and symptoms over follow-up, and the authors describe it as a promising modality. The abstract does not report the presence or absence of harms in detail.
- Participants
- 45
- Who or what was studied
- Patients with refractory meibomian gland dysfunction (45 patients, 90 eyes)
- Limits stated in the abstract
- The abstract does not report the statistical details of any control for bias, and it provides no information on long-term outcomes beyond 32 weeks.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: GRADE, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.